Navigation Links
A Patented Device for Rapid Diagnosis of Diseases

The Ikerlan-IK4 and Gaiker-IK4 Technological Centre have patented a device, which is capable of the rapid // and effective diagnosis of infectious diseases caused by various bacteria, notable amongst which are Salmonella, Campylobacter and Listeria, the causal agents of most gastroenteritis cases due to food poisoning, as well as of other symptomatologies associated with this condition.

With the aim of extending the uses of the device in the field of health, experts at these technological centres are currently researching their application for the detection and treatment of colorectal cancer.

The device incorporates advances in micro-nanotechnology whereby, in a miniaturised laboratory mode, the required reagents are mixed with a sample of the patient. Thanks to miniaturisation, the result of the analysis is obtained in a matter of minutes – very advantageous in providing a rapid and precise diagnosis and one without the need of a laboratory infrastructure, which, in turn, enables a speedy start to treatment.

Reading of the device will be simple based, as it is, on luminous indicators that tell if the result is positive or negative, the identification corresponding to the presence of specific genetic sequences of the microbian agents causing the pathology or of the cancer patient.

Future applications that this microchip could be used for are of great importance, as they can provide genetic diagnosis tools for doctors to carry out early diagnoses of diseases associated with our genetic inheritance or with the malfunctioning of the mechanisms for the translation of our genetic code such as, possibly, the degenerative pathologies of Parkinsons and Alzheimer, amongst others, or of metabolic disorders. Another field of application of great interest is in the forensic field, medical tests for paternity or even prenatal diagnosis.

In this way, Ikerlan-IK4 and Gaiker-IK4 researchers have focused on colorectal cancer in o
'"/>




Page: 1 2

Related medicine news :

1. Injection supports Heart Devices
2. New Heart-Screening Device ,An Accurate Predictor Of Heart Disease
3. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
4. Withdrawal Notice Issued For Older Pacemakers Due To Malfunctioning of the Device
5. New Implantable Device That Can Keep The Heart Ticking
6. Making MRIs Safe for Patients With Implantable Heart Devices
7. Researchers Develop Device For Detecting Atherosclerotic Plaques
8. A Cheap Device to Stop Snoring from New Zealand
9. Scientists Concerned Over Increasing Malfunction Of Heart Devices
10. Device For Improving Bone Mass In Osteoporosis
11. Anti-Microbial Coating For Use Over Biomedical Devices Developed

Post Your Comments:
(Date:11/10/2009)... BoxTone(R), the expert i...ehensive software suite to manage, track and contr...droid 2.0 mobile operating system. The announcemen... BoxTone v5.0, which included new support for othe...pple iPhone, Palm Pre and Windows Mobile. , ...
(Date:11/10/2009)... WAVE (Whole-Body Advance...s expanding its cutting edge vibration exercise te...a, Chile and Uruguay. All three of WAVE’s re...r Reflex and Contour Plus, are now available in So...vember 10, 2009 -- WAVE (Whole-Body Advanced Vibra...
(Date:11/10/2009)... Carrington Nuamah, P.C.,...nkruptcy, immigration and estate law, has unveiled...legal advice can now learn more about the firm at ... Seattle, WA (Lexis Nexis) November 10, 2009 -...nched a new website at www.carringtonnuamah.com ....
(Date:11/9/2009)... Businesses of all sizes ...forts for the H1N1 pandemic have a new resource at...polis (PRWEB) November 9, 2009 -- Human resource ...ess and response efforts for the H1N1 pandemic hav... of Minnesota’s Center for Infectious Diseas...
(Date:11/9/2009)...,, House Delivers on Election Promise. Now Is ...PRNewswire-USNewswire/ -- The following is a state...fter generations of struggle and decades of delay,... to act -- and, to pass historic reform legislatio...ncome, access to high quality, affordable health c...
Breaking Medicine News(10 mins):Health News:BoxTone Delivers Enterprise Mobile User Management for Google Android 2.0 Smartphones 2Health News:BoxTone Delivers Enterprise Mobile User Management for Google Android 2.0 Smartphones 3Health News:WAVE's Revolutionary Whole-Body Advanced Vibration Exercise Is Now Available in South America 2Health News:Seattle Law Firm Carrington Nuamah Launches New Website for Personal Injury, Bankruptcy, Immigration and Estate Law 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 3Health News:Statement of Anna Burger, Chair, Change to Win, on U.S. House Vote for Health Care Reform 2
..., LAWRENCE, Mass., Jan. 6 NxStage Medical, Inc. (...tive dialysis products, today announced that a gro...e-year anniversary of home hemodialysis treatment ...haracterized by better health and well being. , ...
..., BALTIMORE, Jan. 6 FASgen, Inc. is pleased to ...icense agreement with Centocor, Inc. This agreeme...Oncology Research and Development division affilia... Acid Synthase (FAS) for use in Oncology. The FAS...
..., NEW YORK, Jan. 6 MyFoodMyHealth, Inc. today...ww.myfoodmyhealth.com ), a food and wellness,websi...ipes and online tools,designed especially for indi...ing up with one meal everyone at the table can,enj...
..., Company Strengthens Exe... to Handle Legal Affairs. , ...son Healthcare (JH) announced that Dennis J. Stoc... including general corporate compliance, client an...
..., Orion Health has just s... Design Corporation Ltd, becoming a reseller and d...Engine. Trinity Design has already negotiated its... , Auckland, NZ (PRWEB) ...
..., Appointment-Plus softwa...ency of member self-scheduling via the Internet ,...nuary 6, 2009 -- Appointment-Plus, the industry le...rogram providers such as Lifecare, Inc., which ser...
Other Medicine News:Health News:First NxStage Home Hemodialysis Patients Celebrate Five-Year Anniversary 2Health News:First NxStage Home Hemodialysis Patients Celebrate Five-Year Anniversary 3Health News:First NxStage Home Hemodialysis Patients Celebrate Five-Year Anniversary 4Health News:FASgen, Inc. Announces Research and License Agreement With Centocor, Inc. 2Health News:New Website, MyFoodMyHealth, Helps People Manage Multiple Health Conditions Using Delicious Food 2Health News:New Website, MyFoodMyHealth, Helps People Manage Multiple Health Conditions Using Delicious Food 3Health News:Dennis Stockwell Joins Jackson Healthcare as General Counsel 2Health News:Orion Health Signs Trinity Design for Japanese Market 2Health News:Orion Health Signs Trinity Design for Japanese Market 3Health News:Online Scheduling Software Is Revolutionizing the Wellness Industry 2
(Date:11/9/2009)..., PRINCETON, N.J., Nov. 9 /PRNewswire-FirstCall/...nagement will present at the Sixth Annual Lazard C...ce will be held at the St Regis Hotel in New York ... Pharmasset,s President and Chief Executive Office...esday, November 18, 2009 at 3:45 PM (ET). ,, To...
(Date:11/9/2009)...F LAKE, N.J., Nov. 9 Par...y announced that it has extended the expiration da...sly announced "Modified Dutch Auction" tender offe... up to $65,000,000 aggregate principal amount, or ...5% Senior Subordinated Convertible Notes due 2010....
(Date:11/9/2009)..., Nov. 9 MISSION Skincare®, t...tar Serena Williams, soccer professional Mia Hamm,... "Active Lifestyle Skincare Destinations" in the b...ons across the country beginning this week. Stocke...ducts, MISSION and CVS/pharmacy have set out to es...
Breaking Medicine Technology:Pharmasset to Present at Lazard Capital Markets Healthcare Conference 2Pharmasset to Present at Lazard Capital Markets Healthcare Conference 3Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 3Glamour Magazine Woman of the Year and MISSION Skincare Co-Founder, Serena Williams, Teams Up with CVS/pharmacy to Launch National 'Active Lifestyle Skincare Destinations' 2Glamour Magazine Woman of the Year and MISSION Skincare Co-Founder, Serena Williams, Teams Up with CVS/pharmacy to Launch National 'Active Lifestyle Skincare Destinations' 3People With Huntingtons Report Discrimination 48766 1People With Huntingtons Report Discrimination 48766 2People With Huntingtons Report Discrimination 48766 3Salient Mobility Launches the Text For a Cause 28TM 29 Campaign in Raising Awareness Through Wireless Health Tips 48763 1Salient Mobility Launches the Text For a Cause 28TM 29 Campaign in Raising Awareness Through Wireless Health Tips 48763 2RA individuals from lower GDP countries keep working despite worse symptoms than richer countries 48759 1RA individuals from lower GDP countries keep working despite worse symptoms than richer countries 48759 2
...l phase I trial,AFF001, AFFiRiS GmbH has now recru...ial. The trial aims to investigate the tolerabilit...(AFFITOPE AD01). In the trial, all,patients have n...olerated,the vaccine extremely well. The treatment...nthly intervals and is due to be fully completed b...
...maceuticals, Inc. (Nasdaq: MAPP ) announced that ...ng the safety, tolerability and,pharmacokinetics o...e July,issue of Current Medical Research and Opini...orally inhaled and self-administered therapy, as a...ults, which were first announced last year, demons...
Other Medicine Technology:AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine 2AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 2MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 4
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
Medicine Products: